A WHO action plan outlines critical steps to ensure the effectiveness of the world’s most powerful treatment for malaria. The World Health Organization (WHO) has released its Global Plan for Artemisinin Resistance Containment (GPARC), which outlines the steps necessary to prevent the spread of artemisinin-resistant parasites and ensure the effectiveness of artemisinin-based combination therapies (ACTs) as the top-line medicine for treating malaria. Artemisinin-resistant parasites were first detected along the Thailand-Cambodia border several years ago; the WHO stresses that the world must now act quickly so that it does not lose the most effective existing treatment for Plasmodium falciparum malaria.
GPARC outlines five steps for preventing and containing artemisinin resistance:
Stop the spread of resistant parasites.
Increase monitoring and surveillance for artemisinin resistance.
Improve access to malaria diagnostic testing and rational treatment with ACTs.
Invest in artemisinin resistance-related research.
Motivate action and mobilize resources.
The document is a companion to the Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010, which provides the extensive evidence on which the GPARC was based.
http://www.macepalearningcommunity.org/newsletter_whoact.htm
GPARC outlines five steps for preventing and containing artemisinin resistance:
Stop the spread of resistant parasites.
Increase monitoring and surveillance for artemisinin resistance.
Improve access to malaria diagnostic testing and rational treatment with ACTs.
Invest in artemisinin resistance-related research.
Motivate action and mobilize resources.
The document is a companion to the Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010, which provides the extensive evidence on which the GPARC was based.
http://www.macepalearningcommunity.org/newsletter_whoact.htm
No comments:
Post a Comment